Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades

George Ntaios; Gregory Y. H. Lip

doi:10.1055/s-0039-1685454

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2019; 119(05): 685-687
DOI: 10.1055/s-0039-1685454

T&H Historical Series

Georg Thieme Verlag KG Stuttgart · New York

Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades

George Ntaios

¹Department of Internal Medicine, University of Thessaly, Larissa, Greece

,

Gregory Y. H. Lip

²Liverpool Centre for Cardiovascular Science, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, United Kingdom

³Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

› Author Affiliations

Abstract

Full Text

References

References
1 Wright IS. The challenge of cerebral vascular diseases. Thromb Diath Haemorrh 1957; 1 (01) 26-36
2 Wolf P. TREATMENT of a stroke. Lancet 1959; 1 (7067): 293-294
3 Aird RB, Skillicorn SA. The treatment of cerebrovascular accident. Med Clin North Am 1956; 40 (05) 1355-1368
4 Nielsen JM. Management of cerebral vascular accidents. Ann Intern Med 1953; 39 (04) 717-722
5 Furmanski AR. Histamine therapy in acute ischemia of the brain; a report of fifty new cases. AMA Arch Neurol Psychiatry 1953; 69 (01) 104-117
6 Tyler HR. Modern concepts of the pathogenesis, diagnosis and treatment of cerebrovascular accidents. Med Clin North Am 1960; 44: 1215-1236
7 Ebinger M, Winter B, Wendt M. , et al; STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014; 311 (16) 1622-1631
8 Walter S, Kostpopoulos P, Haass A. , et al. Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS One 2010; 5 (10) e13758
9 Psychogios MN, Behme D, Schregel K. , et al. One-stop management of acute stroke patients: minimizing door-to-reperfusion times. Stroke 2017; 48 (11) 3152-3155
10 Papanagiotou P, Ntaios G. Endovascular thrombectomy in acute ischemic stroke. Circ Cardiovasc Interv 2018; 11 (01) e005362
11 Lip GYH, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: Past, present and future. Thromb Haemost 2017; 117 (07) 1230-1239
12 Ntaios G, Hart RG. Embolic stroke. Circulation 2017; 136 (25) 2403-2405
13 Borre ED, Goode A, Raitz G. , et al. Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review. Thromb Haemost 2018; 118 (12) 2171-2187
14 Diener HC, Ntaios G, O'Donnell M, Easton JD. Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke. Expert Opin Pharmacother 2018; 19 (14) 1597-1602
15 Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip GYH. Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Stroke 2017; 48 (09) 2494-2503
16 Proietti M, Mujovic N, Potpara TS. Optimizing stroke and bleeding risk assessment in patients with atrial fibrillation: a balance of evidence, practicality and precision. Thromb Haemost 2018; 118 (12) 2014-2017
17 Loewen PS, Ji AT, Kapanen A, McClean A. Patient values and preferences for antithrombotic therapy in atrial fibrillation. A narrative systematic review. Thromb Haemost 2017; 117 (06) 1007-1022
18 Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials. Int J Stroke 2017; 12 (06) 589-596
19 Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA. , et al. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost 2017; 117 (07) 1448-1454
20 Hohnloser SH, Basic E, Hohmann C, Nabauer M. Effectiveness and safety of non-vitamin K oral anticoagulants in comparison to phenprocoumon: data from 61,000 patients with atrial fibrillation. Thromb Haemost 2018; 118 (03) 526-538
21 Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017; 14 (11) 627-628
22 Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH. Integrated care management of patients with atrial fibrillation and risk of cardiovascular events: the ABC (Atrial fibrillation Better Care) pathway in the ATHERO-AF study cohort. Mayo Clin Proc 2018; S0025-6196(18)30891-7
23 Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway. Am J Med 2018; 131 (11) 1359-1366